The Relationship between C-Reactive Protein/Albumin Ratio and Disease Activity in Patients with Inflammatory Bowel Disease

The Relationship between C-Reactive Protein/Albumin Ratio and Disease Activity in Patients with Inflammatory Bowel Disease

Objectives. The aims of this study were to evaluate the C-reactive protein/albumin ratio (CRP/ALB), inflammatory markers, and parameters from the complete blood count (CBC) in patients with inflammatory bowel disease (IBD) and their associations with disease activity. Methods. A total of 876 IBD pat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi-Han Chen, Li Wang, Shu-Yi Feng, Wei-Min Cai, Xiao-Fu Chen, Zhi-Ming Huang
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Gastroenterology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2020/3467419
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Postoperative Ratio of C-Reactive Protein to Albumin as a Predictive Marker in Patients with Crohn’s Disease Undergoing Bowel Resection
by: Hangfen Zhao, et al.
Published: (2021-01-01)

Potential biomarkers in Behçet’s disease: monocyte, neutrophil, platelet, and C-reactive protein to albumin ratios
by: Mestan Sahin, et al.
Published: (2024-11-01)

Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio
by: Cierra S. Hong, et al.
Published: (2019-01-01)

Effects of Prognostic Nutrition Index, Neutrophil/Lymphocyte Ratio, and C-reactive Protein/Albumin Ratio on Prognosis Undergoing Open Heart Surgery
by: Anil Kilinc, et al.
Published: (2024-11-01)

Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes
by: J. R. Thiele, et al.
Published: (2015-01-01)

Lymphocyte-C-reactive protein ratio upon admission to predict disease progression and ICU admission in adult patients with diabetic ketoacidosis
by: Yi-Jia Hu, et al.
Published: (2025-01-01)

Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease
by: Yu-Chieh Tsai, et al.
Published: (2025-02-01)

The Relationship between Serum Bilirubin and Inflammatory Bowel Disease
by: Xiaojing Zhao, et al.
Published: (2019-01-01)

Immunopathogenesis of inflammatory bowel diseases
by: Ye. A. Konovich, et al.
Published: (2013-09-01)

Inflammatory Bowel Disease and Statins
by: V. V. Genkel, et al.
Published: (2020-04-01)

Somatostatin in inflammatory bowel disease
by: J. D. Van Bergeijk, et al.
Published: (1997-01-01)

Exercise and Inflammatory Bowel Disease
by: Neeraj Narula, et al.
Published: (2008-01-01)

Autoimmunity in Inflammatory Bowel Disease
by: Kiron M Das
Published: (1993-01-01)

Cytokines in inflammatory bowel disease
by: P. L. Beck, et al.
Published: (1997-01-01)

Associations between neutrophil-percentage-to-albumin ratio level and all-cause mortality and cardiovascular disease-cause mortality in diabetes population
by: Geng Shen, et al.
Published: (2025-01-01)

Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease
by: C. J. J. Mulder, et al.
Published: (1998-01-01)

Recognition Functions of Pentameric C-Reactive Protein in Cardiovascular Disease
by: Alok Agrawal, et al.
Published: (2014-01-01)

C-Reactive Protein (CRP) and Autoimmune Disease: Facts and Conjectures
by: Alexander J. Szalai
Published: (2004-01-01)

C-Reactive Protein and Coronary Heart Disease: All Said—Is Not It?
by: Frederik Strang, et al.
Published: (2014-01-01)

The relationship between neutrophil percentage-to-albumin ratio and slow and normal coronary flow phenomenon
by: Renlin Yin, et al.
Published: (2025-01-01)

Association between neutrophil-albumin ratio and ultrasound-defined metabolic dysfunction-associated fatty liver disease in U.S. adults: evidence from NHANES 2017–2018
by: Ming-yu He, et al.
Published: (2025-01-01)

Monocyte Chemotactic Protein 1-Induced Protein 1 Is Highly Expressed in Inflammatory Bowel Disease and Negatively Regulates Neutrophil Activities
by: Jian Lin, et al.
Published: (2020-01-01)

Comment on “Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease”
by: Wenwen Lai, et al.
Published: (2018-01-01)

Vedolizumab for inflammatory bowel diseasesI
by: Igor L. Khalif, et al.
Published: (2018-08-01)

Thrombotic Complications in Inflammatory Bowel Disease
by: A. V. Borota, et al.
Published: (2019-05-01)

Fluticasone Propionate in Inflammatory Bowel Disease
by: Marta Carpani de Kaski, et al.
Published: (1990-01-01)

PPARγ in Inflammatory Bowel Disease
by: Vito Annese, et al.
Published: (2012-01-01)

Treatment of Inflammatory Bowel Disease in Children
by: D Grant Gall
Published: (1990-01-01)

Trends in Inflammatory Bowel Disease Therapy
by: L Sutherland, et al.
Published: (1990-01-01)

Osteomyelitis and Osteonecrosis in Inflammatory Bowel Disease
by: Hugh J Freeman
Published: (1997-01-01)

The Changing Phenotype of Inflammatory Bowel Disease
by: Carthage Moran, et al.
Published: (2016-01-01)

Thromboelastography in Patients with Inflammatory Bowel Disease
by: Yonghua Shen, et al.
Published: (2020-01-01)

Ocular Complications of Inflammatory Bowel Disease
by: Rana Mady, et al.
Published: (2015-01-01)

Cancer Risk in Inflammatory Bowel Disease
by: Anders M Ekbom
Published: (1995-01-01)

Review of Inflammatory Bowel Disease in China
by: Lingna Ye, et al.
Published: (2013-01-01)

T Cell Repertoire and Inflammatory Bowel Disease
by: Kenneth Croitoru, et al.
Published: (1996-01-01)

The Influence of Nutrients on Inflammatory Bowel Diseases
by: Sara Jarmakiewicz-Czaja, et al.
Published: (2020-01-01)

Nonsteroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
by: Ingvar Bjarnason, et al.
Published: (1993-01-01)

Diagnostic interval of inflammatory bowel disease in Chinese children and its relationship with growth parameters: a retrospective study
by: Juan Zhou, et al.
Published: (2025-02-01)

Causal relationship between inflammatory bowel disease and sex: a Mendelian randomization study
by: Kaiwen Wang, et al.
Published: (2025-01-01)